Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4835232

CC(C)Oc1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.50
HDAC1 Q13547 2/20 0.50
HDAC2 Q92769 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
TBK1 Q9UHD2 1/20 0.44
TRPV1 Q8NER1 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
MCL1 Q07820 2/20 0.38
MMP2 P08253 3/20 0.38
MMP9 P14780 3/20 0.38
MMP8 P22894 3/20 0.38
MMP13 P45452 3/20 0.38
DGAT1 O75907 2/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
CHEK2 O96017 2/20 0.36
CBFB Q13951 1/20 0.35
PDE2A O00408 1/20 0.35
PTPN5 P54829 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4839654 0.89 HDAC3 (0.48) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4842876 0.89 CHEK2 (0.45) TBK1MMP2MMP9MMP8MMP13
Trifluoroacetic Acid SCHEMBL4834909 0.86 HDAC6 (0.47) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL5261300 0.83 KDM4E (0.42) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4834060 0.83 KDM4E (0.39) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4842729 0.82 AURKA (0.52) MMP2MMP9MMP8MMP13CHEK2
Trifluoroacetic Acid SCHEMBL5260635 0.82
Trifluoroacetic Acid SCHEMBL4834743 0.82 TRPV3 (0.39) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4841812 0.82 HDAC3 (0.40) HDAC3HDAC1HDAC2HDAC8HDAC6
Trifluoroacetic Acid SCHEMBL4834992 0.82 HDAC3 (0.36) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7410966-B2 Use of and some novel imidazopyridines ASTRAZENECA AB (SE) 2008-08-12 US disclosed
EP-1539759-B1 NOVEL IMIDAZOPYRIDINES AND THEIR USE ASTRAZENECA AB (SE) 2007-08-15 EP disclosed
US-20050261333-A1 Use of and some novel imidazopyridines ASTRAZENECA A B (SE) 2005-11-24 US disclosed
WO-2004016270-A1 USE OF Itk INHIBITORS FOR THE TREATMENT OF MAST CELL-DRIVEN OR BASOPHIL-DRIVEN DISEASES ASTRAZENECA AB (SE) 2004-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261333-A1 Use of and some novel imidazopyridines ITK, CSNK1A1, RPS6KA1 HDAC3 919/4885HDAC1 533/4885HDAC2 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.